-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$1.50-39.02% Downside
Palisade Bio, Inc. Frequently Asked Questions
-
What analysts cover Palisade Bio, Inc.?
Palisade Bio, Inc. has been rated by research analysts at Maxim Group in the past 90 days.